Discovering cytoprotective properties in successful drugs already on the market, or even at the end of their patent term can create new intellectual property and thus extend market exclusivity for the drug.

In addition, establishing the cytoprotective potential of a drug may significantly contribute to the risk-benefit profile of the product.

Zytoprotec offers industry partners to benefit from its extensive experience and know-how in screening and studying pharmaceutical compounds for their cytoprotective profiles.